“Fundamentally Wrong”: Less Than 5% Of Cancer Patients Get Access To Clinical Trials
Long R&D time-line is "unacceptable," says Memorial Sloan Kettering cancer specialist Bob Li
Long R&D time-line is "unacceptable," says Memorial Sloan Kettering cancer specialist Bob Li